Výsledky vyhledávání - "George J. Joseph"

Akademický článek

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

Autor: Eytan M. Stein, Min Yang, Annie Guerin, Wei Gao, Philip Galebach, Cheryl Q. Xiang, Subrata Bhattacharyya, Gaetano Bonifacio, George J. Joseph

Publikováno v: Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-12 (2018)

Abstract Background Preference valuations of health status are essential in health technology and economic appraisal. This study estimated utilities for treatment-related health states of acute myeloid leukemia (AML) and disutilities of severe advers

Externí odkaz: https://doaj.org/article/d237ba30b31c4c1a8cd41e5c026b90bd

Zobrazit plný text záznamu

Plný text ve formátu HTML

Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective

Autor: Thomas A. Albini, Patrick Gagnon-Sanschagrin, Annie Guerin, George J. Joseph, Elizabeth Serra, Jérôme Bédard, Seenu M. Hariprasad, S Bhattacharyya

Publikováno v: BMJ Open Ophthalmology, Vol 6, Iss 1 (2021)
BMJ Open Ophthalmology

ObjectiveTo describe patient characteristics and healthcare costs associated with uveitic macular oedema (UME) in US clinical practices from a commercial payer’s perspective.Methods and analysisThe IBM MarketScan Commercial Subset (1 October 2015�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5890944043f84280a583f2e7128636d0
https://bmjophth.bmj.com/content/6/1/e000896.full

Zobrazit plný text záznamu

Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective

Autor: Ehab Atallah, Briana Ndife, Karen Habucky, Annie Guerin, George J Joseph, Irina Pivneva, Dominick Latremouille-Viau, Ellen K. Ritchie

Publikováno v: Leukemia & Lymphoma. 60:1476-1484

Tyrosine kinase inhibitor (TKI) therapy discontinuation practice in patients with chronic myeloid leukemia chronic phase (CML-CP) was assessed in real-world practice prior to the release of recommendations on discontinuation. Data were collected from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2cdb4aebbf4583ec353f9ba67ac0ac0
https://doi.org/10.1080/10428194.2018.1538510

Zobrazit plný text záznamu

Plný text ve formátu HTML

Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis

Autor: Eric Q. Wu, Gaetano Bonifacio, Annie Guerin, Xiting Cao, George J Joseph, Dominick Latremouille-Viau, Eytan M. Stein, Sherry Shi

Publikováno v: Leukemialymphoma. 62(6)

Background: Hypomethylating agents (HMA), azacitidine (AZA) and decitabine (DEC), are the current standard of care in patients with intermediate-2 and high risk myelodysplastic syndromes (MDS) by IPSS prognostic category (higher-risk MDS) based on cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d25b948ee67fdc87214039199d9557
https://pubmed.ncbi.nlm.nih.gov/33430673

Zobrazit plný text záznamu

Plný text ve formátu HTML

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States

Autor: Michael L. Volk, Annie Guerin, Sherry Shi, Maliha Ahmad, Rebecca Burne, George J. Joseph, Zeev Heimanson

To assess healthcare costs and hospitalization rates associated with rifaximin therapy versus lactulose alone among patients at risk for hepatic encephalopathy (HE). IBM Marketscan Commercial and Optum’s de-identified Clinformatics Data Mart databa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c55b37e52d1449e9b21dcf1afa3a12

Zobrazit plný text záznamu

Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations

Autor: Dominick Latremouille-Viau, Eytan M. Stein, Sherry Shi, George J Joseph, Annie Guerin, Patrick Gagnon-Sanschagrin, Owanate Briggs, Gaetano Bonifacio

Publikováno v: Journal of Medical Economics. 21:556-563

Objective: To describe the setting, duration, and costs of induction and consolidation chemotherapy for adults with newly-diagnosed acute myeloid leukemia (AML), who are candidates for standard induction chemotherapy, in the US. Methods: Adults newly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783f5a8801cfd0d04995e542dbe75e41
https://doi.org/10.1080/13696998.2018.1425209

Zobrazit plný text záznamu

Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency

Autor: Benjamin Garrett Cohen, Dominick Latremouille-Viau, Patrick Gagnon-Sanschagrin, Katherine Dea, Annie Guerin, George J Joseph

Publikováno v: Journal of Managed Care & Specialty Pharmacy. 23:214-224

Frequent molecular monitoring (qPCR tests), as recommended by evidence-based monitoring guidelines, is associated with higher adherence to tyrosine kinase inhibitors (TKIs) in the management of chronic myeloid leukemia (CML); both factors have been a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e81df40fc5e33113d5da3bae6673431b
https://doi.org/10.18553/jmcp.2017.23.2.214

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání